http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-1607134-C
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_153ae69eed34c3caf715379b30dd185f |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-537 |
| filingDate | 1986-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1993-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e5ef276098f35f19da2012eb2377807 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1c5a7ed6b6d2897a95fee216aeb2995 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_27a6555dee726544eacdeedfd06c78b1 |
| publicationDate | 1993-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-1607134-C |
| titleOfInvention | Method of treating cancer of ovary |
| abstract | The invention relates to oncology. The goal is to increase the survival of cancer patients with stages o. To do this, simultaneously with chemotherapy, a suspension of 125 mg of hydrocortisone is administered twice with a break of 7-8 days. This allows to shorten the hospital stay, and lengthens the length of the disease-free period. |
| priorityDate | 1986-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 18.